Sinovac’s COVID-19 vaccine highly effective against serious illness: study [TechCrunch Blog]
Pfizer, Inc. (PFE)
Last pfizer, inc. earnings: 4/28 06:45 am
Check Earnings Report
US:NYSE Investor Relations:
investors.pfizer.com/investors-overview/default.aspx
Company Research
Source: TechCrunch Blog
Sinovac’s COVID-19 vaccine is highly effective against serious illness, although rival shots from Pfizer/BioN and AstraZeneca showed better protection rates, a large real world study from Malaysia showed.The latest data is a boost to the Chinese firm, whose COVID-19 vaccine has been under growing scrutiny over its effectiveness following reports of infections among healthcare workers fully immunized with the Sinovac shot in Indonesia and Thailand.The study, conducted by the Malaysian government, found that 0.011% of about 7.2 million recipients of the Sinovac shot required treatment in intensive care units (ICU) for COVID-19 infections, health officials told reporters on Thursday.By contrast, 0.002% of about 6.5 million recipients of the Pfizer/BioN vaccine needed ICU treatment for COVID-19 infections, while 0.001% of 744,958 recipients of the AstraZeneca shot required similar treatment.Kalaiarasu Peariasamy, a director at the Institute for Clinical Research that conducted the study a
Show less
Read more
Impact Snapshot
Event Time:
PFE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PFE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PFE alerts
High impacting Pfizer, Inc. news events
Weekly update
A roundup of the hottest topics
PFE
News
- Everest Medicines Announces Financial Results for Full Year Ended December 31, 2023 [Yahoo! Finance]Yahoo! Finance
- Global Metastatic Melanoma Therapeutics Market Anticipates Robust Growth with New Therapeutic Developments [Yahoo! Finance]Yahoo! Finance
- CStone Pharmaceuticals Reports 2023 Annual Results and Business Updates [Yahoo! Finance]Yahoo! Finance
- Is Most-Watched Stock Pfizer Inc. (PFE) Worth Betting on Now? [Yahoo! Finance]Yahoo! Finance
- US Pharmaceutical Market Review 2020-2023 and Forecast 2024-2030: A $1.28 Trillion Opportunity, Driven by the Rising Adoption of AI-based Tools for Drug Discovery [Yahoo! Finance]Yahoo! Finance
PFE
Earnings
- 1/30/24 - Beat
PFE
Sec Filings
- 3/18/24 - Form 4
- 3/18/24 - Form 4
- 3/14/24 - Form ARS
- PFE's page on the SEC website